CanadaBis Capital (CANB) AI Stock Analysis

• Market Cap: C$6.22M
• Dividend Yield: N/A
• Average Volume (3M): 32.35K
• Price to Earnings (P/E): 90.0
• Beta (1Y): -0.51
• Revenue Growth: -8.84%
• EPS Growth: -96.82%
• Country: CA
• Employees: N/A
• Sector: Services
• Sector Strength: N/A
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): 0.00
• Shares Outstanding: 138,256,380
• 10 Day Avg. Volume: 4,700
• 30 Day Avg. Volume: 32,346
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: C$0.00 ▼(-100.00% Downside)

CanadaBis Capital's overall stock score is primarily impacted by weak financial performance and overvaluation concerns. The technical analysis also indicates a bearish trend, further weighing down the score.

CanadaBis Capital Business Overview & Revenue Model

Company Description

CanadaBis Capital Inc. is a diversified cannabis company operating in Canada, focusing on the cultivation, production, and distribution of cannabis and cannabis-related products. The company is actively involved in the cannabis sector through its various business segments, which include the production of premium cannabis strains and the development of cannabis derivatives and infused products. It aims to capitalize on the growing cannabis industry by leveraging its expertise in cultivation and processing.

How the Company Makes Money

CanadaBis Capital Inc. generates revenue primarily through the sale of its cannabis products, which include dried flower, oils, and derivative products such as edibles and concentrates. The company's revenue streams are bolstered by its cultivation facilities and processing capabilities, which enable it to produce high-quality cannabis products at scale. In addition to direct sales to consumers and medical patients, CanadaBis Capital also engages in wholesale transactions with other licensed producers and retailers. Key partnerships with distributors and retailers enhance its market reach and contribute significantly to its earnings.

CanadaBis Capital Financial Statement Overview

Summary

CanadaBis Capital's financial performance is under pressure with declining revenue growth and low profitability, high leverage, and negative cash flow challenges. Despite a healthy gross margin, these factors indicate significant financial instability.

Income Statement

CanadaBis Capital's income statement shows a mixed performance. The company has experienced a decline in revenue, with a revenue growth rate of -4.41% in the TTM. Gross profit margin is healthy at 46.16%, but net profit margin is very low at 0.41%, indicating challenges in converting revenue into net income. The EBIT margin of 2.62% and EBITDA margin of 9.00% suggest limited operational efficiency and profitability.

Balance Sheet

The balance sheet presents moderate financial stability. The debt-to-equity ratio is high at 1.06, indicating significant leverage and potential risk. The equity ratio stands at 34.66%, providing a moderate cushion against liabilities. Return on equity (ROE) is low at 0.81%, reflecting limited returns generated on shareholders' equity.

Cash Flow

Cash flow analysis reveals concerns with a negative free cash flow and a substantial drop in operating cash flow. The free cash flow growth rate is significantly negative, and both the operating cash flow to net income ratio and free cash flow to net income ratio indicate challenges in cash generation relative to earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	17.16M	17.95M	22.22M	11.67M	6.87M	4.43M
Gross Profit	7.92M	8.82M	11.78M	5.57M	2.52M	1.16M
EBITDA	1.54M	2.09M	5.68M	1.63M	-1.81M	-4.43M
Net Income	69.93K	600.28K	4.44M	608.33K	-2.68M	-5.39M
Balance Sheet
Total Assets	24.98M	24.55M	22.96M	15.48M	13.28M	12.52M
Cash, Cash Equivalents and Short-Term Investments	947.97K	1.68M	3.23M	144.88K	849.50K	167.00K
Total Debt	9.18M	6.44M	7.31M	7.82M	8.44M	6.06M
Total Liabilities	16.23M	16.45M	15.62M	12.84M	11.46M	9.09M
Stockholders Equity	8.66M	8.00M	7.25M	2.54M	1.73M	3.34M
Cash Flow
Free Cash Flow	-3.13M	-594.48K	4.57M	-292.54K	-1.96M	-8.58M
Operating Cash Flow	-2.95M	-256.31K	5.55M	-82.77K	-1.81M	-3.62M
Investing Cash Flow	-176.12K	-328.33K	-965.82K	-209.77K	122.77K	-2.39M
Financing Cash Flow	2.69M	-962.02K	-1.50M	-412.09K	2.37M	5.85M

CanadaBis Capital Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CANB, the sentiment is Negative. The current price of 0.04 is above the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.04, and below the 200-day MA of 0.06, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 45.92 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CANB.

CanadaBis Capital Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CANB	41 Neutral	C$6.22M	90.00	0.83%	―	-8.84%	-96.82%
IMCC	39 Underperform	9.29M	-3.26	-201.89%	―	2.17%	88.34%
PCLO	24 Underperform	6.92M	-0.84	―	―	125.70%	47.09%
Sector *	55 Neutral	$13.29B	17.42	10.03%	0.93%	7.13%	-12.93%

CanadaBis Capital Corporate Events

CanadaBis Capital Achieves Positive Q3 2025 Financial Results Amid Market Challenges

CanadaBis Capital has reported its financial results for Q3 2025, achieving a positive adjusted EBITDA of $440,665 despite a challenging market environment. The company recorded gross sales of $5.5 million and a 6% increase in gross earnings over previous periods. Strategic cost management and product innovation, including the launch of diamond and Keef-coated pre-rolls, have been pivotal in maintaining operational efficiency. Additionally, CanadaBis has reduced its short-term debt by $2.5 million and plans to launch innovative vape hardware later this year, positioning itself for future growth in the cannabis sector.